logo
15:59 Jan 29

Aurobindo Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1150.60
+10.70 (+0.94%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Aurobindo Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1150.60
+10.70 (+0.94%)
15:59 Jan 29
Quality
image/svg+xml

54/100
Medium Financial Strength

Valuation
image/svg+xml

43/100
Mid Valuation

Technical

44/100
Technically Neutral

Strength

8

Weakness

3

Opportunity

0

Threats

0

10.67 %

ROE %

7.00 %

ROA %

58.93

EPS

562.21

BVPS

10.98 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
24774.62 23455.49 24855.38 29001.87 31723.73
Operating Expenses +
19441.22 19068.72 21136.74 23158.87 25140.94
Raw Material
10632.68 9323.6 11702.94 13549.07 13623.87
Increase Decrease in Cost
-730.21 816.68 -409.68 -946.17 -597.63
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
3535.02 3450.92 3522.25 3922.94 4475.62
Miscellaneous Expenses
10634.57 9381.06 10422.09 12178.89 13413.3
Operating Profit
5333.4 4386.77 3718.64 5843 6582.79
Other Income
380.85 320.35 290.59 557.38 621.85
Depreciation
1055.39 1126.52 1244.58 1521.66 1649.42
Interest
74.49 48.64 140.48 289.71 457.24
Profit before tax and exceptio..
4584.37 3531.96 2624.17 4589.01 5097.98
Exceptional Items
2814.58 -127.97 0 -191.86 0
PBT
7398.95 3403.99 2624.17 4397.15 5097.98
Provision for Taxation
2009.77 725.63 684.85 1211.02 1582.72
Net Profit
5389.18 2678.36 1939.32 3186.13 3515.26
NET Profit after MI
5334.84 2648.15 1927.5 3172.97 3485.88
EPS
91.05 45.19 32.9 54.16 59.81
Operating Profit Margin (%)
21.53 18.7 14.96 20.15 20.75
Net Profit Margin (%)
21.53 11.29 7.75 10.94 10.99

Aurobindo Pharma Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: